Vía de la Hispanidad, 21
Araclon Biotech is a company dedicated to the research and development of therapies and diagnostic methods to be applied to degenerative diseases, currently focusing on Alzheimer’s disease. At present, Araclon is working on four different projects:
The first of these focuses on the diagnosis of Alzheimer’s disease (with a detection kit for beta-amyloid 40 and 42 proteins in blood already patented).
The second is centred on Alzheimer’s therapy (immunotherapy based).
The third is an emerging project, which attempts to respond to the challenge of predicting Alzheimer’s disease in totally asymptomatic individuals.
And finally, a project related to the development of a therapy for the Parkinson’s disease
CEO: Manuel Saras
Please click here for clinical trial information.